Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

Laetitia Comps-Agrar - Senior Scientist, Biochemical and Cellular Pharmacology

Laetitia Comps-Agrar

Senior Scientist, Biochemical and Cellular Pharmacology

"I am fortunate to work in such a highly collaborative environment with top-tiered scientists, who aim at conducting high quality science and translate it into transformative medicines for patients."
9
Years at Genentech
10
Publications
2
Awards & Honors

I obtained a PhD in Molecular Pharmacology at the University of Montpellier, France, where I studied the pharmacology of G-protein coupled receptors and delineated how their oligomerization influences their physiological function. I joined Genentech as a post-doctoral fellow in 2011. During that time, I was involved in three research projects that translated into molecules that made it to the clinic. This was an exciting time that contributed to my decision to stay with the company as a scientist and lead my own lab. I could not think of a better place to do science at its highest level and translate these findings into therapeutics that could benefit patients.

Currently, my group supports therapeutic antibodies efforts within multi-disciplinary project teams in the therapeutic areas of ocular, cancer-immunology and oncology.

Featured Publication

Massive antibody discovery used to probe structure-function relationships of the essential outer membrane protein LptD.

Elife 8. pii: e46258. (2019).

Storek KM, Chan J, Vij R, Chiang N, Lin Z, Bevers J 3rd, Koth CM, Vernes JM, Meng YG, Yin J, Wallweber H, Dalmas O, Shriver S, Tam C, Schneider K, Seshasayee D, Nakamura G, Smith PA, Payandeh J*, Koerber JT*, Comps-Agrar L*, Rutherford ST*. (*co-corresponding author)

Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.

J Biol Chem. 290(40):24166-77. (2015).

Comps-Agrar L*, Dunshee DR, Eaton DL, Sonoda J*. (*co-corresponding author)

The immunoreceptor TIGIT regulates anti-tumor and anti-viral CD8+ T cell effector function.

Cancer Cell 26(6):923-37. (2015).

Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, Park S, Javinal V, Chiu H, Irving B, Eaton DL, Grogan JL.